Category Archive for "News for Industry"

Accurexa Announces License For UCSF Brain Stem Cell Device (Bay Street)

Posted in: News for Industry, News for Researchers | September 17, 2014

(San Francisco, CA) The University of California, San Francisco announced that it has entered into an exclusive license agreement with Accurexa, Inc for global licensing of a medical stereotactic...

BioTime’s Cell Cure Neurosciences Ltd. Demonstrates Safety and Efficacy of OpRegen® in Animal Studies (Market Watch)

Posted in: News for Industry | September 17, 2014

(Alameda, CA) BioTime Inc. completed a series of extensive preclinical safety and efficacy studies for its product OpRegen intended for treatment of dry age-related macular degeneration....

New Stem Cell Bio Drug for Bone Regeneration To Be Released in January (Miami Today News)

Posted in: News for Doctors, News for Industry, News for Patients | September 17, 2014

(Miami, FL) An adult bone marrow isolated multi-lineage inducible cell called the Miami cell....

Pluristem Pursues Development Strategy in Japan Where New Law Accelerates Path to Market (CNN)

Posted in: News for Industry | September 17, 2014

(Haifa, Israel) Pluristem Therapeutics Inc. a leading developer of placenta-based cell therapy products is evaluating strategic opportunities to co-develop and commercialize cell therapy products in Japan....

Scientists Create Therapy-Grade Stem Cells Using New Cocktail to Reprogram Adult Cells (Phys)

Posted in: News for Industry, News for Researchers | September 16, 2014

(Jerusalem, Israel) Researchers at the Hebrew University of Jerusalem have developed a new formulation that is highly effective in transforming adult stem cells into quality pluripotent stem cells....

Global Market for Stem Cells to Reach $10.6 Billion in 2018; The Americas Growing at 13.9% Annually (BCC Research)

Posted in: News for Industry | September 16, 2014

(Wellesley, MA) BCC research reveals that the global market for stem cells is expected to grow to nearly $10.6 billion by the year 2018....

Cleveland BioLabs Announces Approval to Start Phase 1 Study for Hematopoietic Stem Cell Mobilizer in Russian Federation (Market Wired)

Posted in: News for Industry, News for Researchers | September 15, 2014

(Buffalo, NY) Cleveland BioLabs Inc. receive approval from the Russian Ministry of health to begin phase 1 clinical trials for the induction and mobilization of hematopoietic stem cells....

Medipost America Clears Phase For IND Stem Cell Clinical Trial (Business Wire)

Posted in: News for Industry | September 14, 2014

(Rockville, MD) MEDIPOST America Inc. announced US FDA approval of a phase 1/2 clinical trial for PNEUMOSTEM for newborn infants who will be at high risk for developing bronchopulmonary...